Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC
Abroad (travel likely)RecruitingPHASE3
Conditions
Head and Neck Squamous Cell Carcinoma · Neoadjuvant Therapy · Pembrolizumab
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Beijing Tongren Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Yang Zhang) · zhangyazhangyangent@163.comngent@163.com · +86 13311365369
Study leads
Zhigang Huang
Study Chair
Beijing Tongren Hospital